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CORRESPONDENCE
Alpha-thalassaemia trait as a cause of 
unexplained microcytosis in a South 
African population
To the Editor: I read the article by Loonat et al.[1] with interest. In 
the early 1980s a study was undertaken at Red Cross War Memorial 
Children’s Hospital, Cape Town, South Africa (SA), to assess the 
frequency with which a low red cell mean corpuscular volume 
(MCV) was associated with the presence of thalassaemia or an 
abnormal haemoglobin.[2] Between January 1979 and December 
1980, 730 patients with an MCV of ≤60 fl were investigated. Forty-six 
(6.4%) were found to carry a β-thalassaemia gene and 20 (2.7%) had 
an abnormal haemoglobin, most commonly Hb E. The prevalence of 
thalassaemia was highest in individuals of mixed ethnic origin, and 
abnormal haemoglobins were found exclusively in this population, 
although the numbers of white and black patients were much 
smaller in comparison. Alpha-thalassaemia was not tested for, as the 
technology was unavailable at the time owing to cost constraints. 
Nevertheless the findings confirmed that patients with persistent 
unexplained microcytosis/hypochromia should be screened for 
thalassaemia and haemoglobin variants.
A further survey of blood donors of mixed racial origin was 
undertaken to determine the prevalence of inherited haemoglobin 
disorders in this population more accurately.[3] Globin synthesis 
studies and DNA analyses were performed in donors with 
microcytosis or hypochromia or both associated with normal 
ferritin, Hb A2 and Hb F levels. DNA was analysed by Southern 
blotting and hybridisation with an α-globin complementary DNA 
probe and a γ-globin genomic probe. In 989 donors screened, Hb S 
and E were the commonest structural variants detected, each with a 
prevalence of 1%. Hb C was detected in just 1 donor. Seven donors 
had β-thalassaemia trait (0.8%) and 2 had hereditary persistence of 
fetal haemoglobin. A total of 45 donors had DNA analyses. Thirty-
three were documented as having α-thalassaemia, the majority 
(n=24) of whom were heterozygous for the α+ (–α/) haplotype, with 
an observed frequency of 0.023.
I am not clear whether other haemoglobin variants, in particular 
Hb E, were screened for in the study by Loonat et al.[1] Hb E was 
first described in Thailand and is common in South-East Asia. Many 
South-East Asians who were brought to the Cape in the early years 
of settlement were from Indonesian islands, and presumably this 
accounts for the presence of Hb E in the mixed-race population of 
the Western Cape. The heterozygous and homozygous states for Hb E 
are benign conditions clinically, but individuals often have red cell 
microcytosis and/or hypochromia.[4] The βE gene results in inefficient 
synthesis, as borne out by studies that show decreased βE globin chain 
synthesis,[5] and there is also evidence that the βE messenger RNA is 
relatively unstable.[6] It therefore appears that the βE gene leads to a 
mild form of β-thalassaemia. The double heterozygous condition 
of Hb E/β-thalassaemia is, however, a major public health hazard 
in the Far East, India, Pakistan and Bangladesh, with a clinical 
picture akin to that of thalassaemia major. Milder forms of Hb E/β-
thalassaemia have also been described and are perhaps the result of 
Hb E interaction with β+-thalassaemia.
With regard to α-thalassaemia, other studies in southern Africa 
include those of Ramsay and Jenkins,[7] Mathew et al.[8] and Rousseau 
and Mathew. [9] The former studied a group of San in the Kalahari 
region of Namibia and found the –α/ determinant to occur at a 
frequency of 0.06. They postulated that the –α/ haplotype has a 
significant protective effect against malaria. Rousseau and Mathew[9] 
performed follow-up DNA analyses on neonates with Hb Bart’s 
detected in cord blood samples. The –α/ determinant was the most 
frequent haplotype and the observed frequency was very similar to 
that in the donor study. Krause et al.[10] summarised their 30-year 
experience in testing for haemoglobinopathies in Johannesburg: five 
common α-globin deletions were identified with 10 genotypes. The 
most common deletion identified was –α3.7 in individuals of different 
ethnicities.
Red cell microcytosis/hypochromia is most commonly caused by 
iron deficiency and chronic inflammatory or infectious disorders. 
However, in patients with persistent unexplained microcytosis and/
or hyopchromia following a thorough haematological assessment, 
a full investigation for the presence of a haemoglobinopathy is 
warranted. Haemoglobinopathies are not the most common mono-
genic disorders in SA, but from the data summarised above it is clear 
that they do occur at significant frequencies in high-risk minority 
groups, and when detected appropriate genetic counselling can 
be offered. It is also important that these patients are identified, 
since they may receive inappropriate chronic therapy such as iron 
medication.
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